4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001415889-25-015971
Director acquired 5,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BIENAIME JEAN JACQUES Director | 2025-06-04 | Grant or award | +5,250 | 5,450 | D | ||
| Derivatives | |||||||
| BIENAIME JEAN JACQUES Director | 2025-06-04 | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | D | ||
Loading xslF345X05/form4-06062025_040601.xml…